Catalyst Wire Dossier Catalyst Wire Dossier

Rasilamlo

aliskiren;amlodipine · Novartis Europharm Ltd
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Rasilamlo, covering 2017-03-28 to 2017-03-28. Get the full timeline:

Most recent: EMA Withdrawn: Rasilamlo (aliskiren;amlodipine) — Novartis Europharm Ltd

See pricing